AQP3 and breast cancer: Immunoreactivity analysis showed that ER-positive breast cancer tissues obtained from premenopausal patients had higher AQP3 level than those obtained from postmenopausal patients, and treating ER-positive breast cancer cells with E2 not only upregulated the expression of AQP3, but also promoted cell migration and invasion.